Envair Electrodyne Limited has announced its unaudited financial results for the quarter and nine months ended December 31, 2025, showcasing a significant operational turnaround. The Board of Directors approved these results during their meeting held on February 12, 2026, with the financial statements being subject to limited review by M L Bhuwania and Co LLP, Chartered Accountants.

Quarterly Performance Analysis

The company's Q3FY26 performance marked a substantial improvement compared to the corresponding period in the previous year. The financial metrics demonstrate the company's recovery trajectory across key parameters.

Nine-Month Cumulative Results

The nine-month performance further reinforces the company's improved operational efficiency and cost management initiatives. The cumulative results show sustained profitability compared to the previous year's losses.

Revenue and Cost Structure

The company's revenue structure remained consistent with previous periods, with total income derived entirely from other income sources. Revenue from operations remained nil across all reported periods. The expense management showed improvement with:

• Employee benefit expenses: ₹2.80 lakhs in Q3FY26 versus ₹2.71 lakhs in Q3FY25
• Other expenses: ₹4.20 lakhs in Q3FY26 compared to ₹4.88 lakhs in Q3FY25
• Finance costs: Remained nil across all periods

Tax Position and Capital Structure

The company reported current tax expense of ₹0.82 lakhs for Q3FY26, significantly lower than the ₹64.29 lakhs recorded in Q3FY25. The paid-up equity share capital remained stable at ₹464.00 lakhs with a face value of ₹10 per share throughout all reported periods.

Business Outlook and Operations

According to the financial statements, Envair Electrodyne Limited operates in a single reportable segment of industrial machinery. The management indicated they are exploring new opportunities to establish manufacturing or trading business operations, suggesting potential diversification strategies for future growth.

The auditor's limited review report, conducted by M L Bhuwania and Co LLP, confirmed that the financial results comply with Indian Accounting Standards and regulatory requirements under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Envair Electrodyne Limited has announced its unaudited financial results for the second quarter and half year ended September 30, 2025. The company's performance shows a mixed picture with a decline in profits but growth in assets and equity.

Financial Performance

The company reported the following key financial metrics:

The figures indicate a significant decline in quarterly profit, with Q2 FY26 profit falling by about 84% compared to the same quarter last year.

Balance Sheet Highlights

As of September 30, 2025, the company's financial position shows some improvements:

The company has seen an increase in total assets and a significant improvement in cash position. Notably, Envair Electrodyne has eliminated its short-term borrowings, which stood at ₹2.40 lakhs in March 2025.

Board Approval and Disclosure

The Board of Directors approved these results in a meeting held on November 13, 2025. The meeting commenced at 01:45 PM and concluded at 02:40 PM. The company has submitted these results in compliance with Regulation 33 and other applicable regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Conclusion

While Envair Electrodyne faces challenges with declining profits, the company has shown improvements in its balance sheet, particularly in asset growth and debt reduction. The company's strategies to improve profitability in the coming quarters may be of interest to investors and stakeholders.